Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-039561

Director acquired 3,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dunsire Deborah · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-24 Grant or award : show line 1 in the form +3,300 15,870 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-24 Grant or award : show line 2 in the form Stock Option (Right to Buy) +6,245 6,245 D
Loading xslF345X03/doc4.xml…